Investigación sobre Longevidad
Compuestos para investigación del envejecimiento celular y la inmunidad. A continuación se encuentra la literatura publicada para cada compuesto en esta área — 199 estudios en total, 60 de ellos publicados desde 2023, cada uno vinculado a su registro fuente.
- LongevidadClínico temprano
Epithalon
Epithalon (also written Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), derived from the pineal gland extract preparation Epithalamin. Published work reports induction of telomerase activity and telomere elongation in cultured human cells, modulation of circadian and pineal gene expression, antioxidant effects, and extension of median lifespan in Drosophila and rodent models. The great majority of this literature originates from a single Russian research group, with a small number of independent in vitro replications appearing between 2022 and 2025. No registered, placebo-controlled randomised trial of the tetrapeptide in humans has been published in the indexed literature.
- Estudios
- 21
- Desde 2023
- 8
- Más reciente
- 2026
- LongevidadClínico temprano
Glutathione
Glutathione (GSH) is an endogenous tripeptide (glutamate-cysteine-glycine) that functions as the principal intracellular thiol antioxidant and redox buffer. Human research falls into four broad strands: pharmacokinetic work comparing standard oral, liposomal/micellar and intravenous delivery; dermatological trials of oral, topical and intravenous glutathione for skin pigmentation; clinical trials of intravenous, inhaled or oral glutathione in conditions such as contrast-induced kidney injury, chemotherapy neuropathy and cystic fibrosis, with mixed and often null results; and precursor-based repletion strategies, most prominently glycine plus N-acetylcysteine (GlyNAC), studied in ageing, HIV and metabolic disease. Trial sizes are generally small, outcome measures are heterogeneous, and results in neurodegeneration have been largely negative for direct glutathione administration while precursor approaches have shown more consistent biochemical effects.
- Estudios
- 43
- Desde 2023
- 12
- Más reciente
- 2026
- LongevidadClínico temprano
LL-37
LL-37 is the sole human cathelicidin antimicrobial peptide, a 37-residue amphipathic alpha-helical peptide released by proteolytic cleavage of the hCAP18 precursor encoded by the CAMP gene. It is expressed by neutrophils, monocytes and epithelial cells, transcriptionally induced by 1,25-dihydroxyvitamin D3, and acts through direct membrane permeabilisation of microbes, neutralisation of lipopolysaccharide, and receptor-mediated chemotaxis and immunomodulation. Its biological effect is strongly concentration- and context-dependent, and elevated LL-37 is implicated as a pathogenic driver in rosacea, psoriasis and atherosclerosis as well as a host-defence effector. The great majority of the literature is in vitro or animal work; human interventional data are limited to a small number of topical and oral formulations.
- Estudios
- 22
- Desde 2023
- 13
- Más reciente
- 2026
- LongevidadClínico
Thymalin
Thymalin is a polypeptide complex extracted from calf thymus, developed in the Soviet Union by Morozov and Khavinson and used in Russia as an immunocorrective medicine; the dipeptide Thymogen (Glu-Trp) was later isolated from it. Cell studies from the developing group reported that Thymalin promoted differentiation of human haematopoietic stem cells toward mature T cells and reduced inflammatory cytokine production, effects attributed to short peptides such as KE and EW. Mouse studies in the 1980s reported longer life span and fewer spontaneous tumours with the thymus polypeptide factor, and a 6-8-year study in 266 older people reported lower respiratory disease incidence and mortality with Thymalin with or without Epithalamin. During the COVID-19 pandemic the same group reported faster normalisation of inflammatory and coagulation markers and lower hospital mortality when Thymalin was added to standard care. Much of this evidence comes from the developing group and its collaborators, with further small Soviet and Russian clinical studies from other centres in infections, surgery, endocrine and skin disease; much of it is in Russian, and the clinical studies were small and not described as blinded or randomised.
- Estudios
- 34
- Desde 2023
- 1
- Más reciente
- 2023
- LongevidadFármaco aprobado
Thymosin Alpha-1
Thymosin alpha-1 (Ta1, thymalfasin) is a 28-amino-acid peptide derived from prothymosin alpha and originally isolated from thymic tissue. It acts largely through Toll-like receptor signalling on dendritic cells and monocytes, influencing T-cell differentiation, thymic output and cytokine balance. It is registered as a prescription immunomodulator in a number of countries, principally for chronic hepatitis B and as an adjuvant in sepsis and oncology, and has been studied in more than thirty controlled human trials. It is not approved by the FDA or EMA.
- Estudios
- 39
- Desde 2023
- 16
- Más reciente
- 2026
- LongevidadClínico
VIP
Vasoactive intestinal peptide is a 28-amino-acid neuropeptide that signals through the class B G protein-coupled receptors VPAC1 and VPAC2, with documented roles in pulmonary vasodilation, surfactant regulation, suppression of pro-inflammatory cytokine release, regulatory T cell induction, and synchronisation of circadian pacemaker neurons in the suprachiasmatic nucleus. Its synthetic form, aviptadil, has been tested in humans for COVID-19-associated acute hypoxaemic respiratory failure, sarcoidosis and erectile dysfunction. The largest randomised trial in respiratory failure (TESICO) found no significant clinical benefit for intravenous aviptadil versus placebo, and a 2025 systematic review of ARDS trials reported a pooled survival odds ratio of 1.01, while smaller inhaled-route and open-label studies reported favourable but non-definitive signals. An aviptadil-phentolamine intracavernosal combination is an established second-line agent in erectile dysfunction practice.
- Estudios
- 40
- Desde 2023
- 10
- Más reciente
- 2026
Investigación publicada más reciente
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Frontiers in Aging · narrative review of nine therapeutic peptides used or investigated in aging research, including Epithalon
PubMed · 42021992A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial
Antioxidants (Basel) · randomized double-blind crossover, 14 healthy adults, single oral doses of micellar vs standard vs liposomal glutathione, plus 30-day single-arm safety phase at 600 mg/day
PubMed · 41897500Efficacy and Safety of Glutathione Supplementation in Patients with HIV Infection and HIV-Tuberculosis Co-Infection
Nutrients · review of mechanistic studies, clinical trials and translational research on glutathione and precursor supplementation in HIV and HIV-tuberculosis co-infection
PubMed · 41754089Formulation-dependent differences in systemic glutathione availability: Comparative pharmacokinetics of orally dissolving film and tablet formulations in healthy adults
European Journal of Pharmaceutics and Biopharmaceutics · randomized open-label crossover single-dose 300 mg pharmacokinetics, plus 4-week supplementation at 100 mg/day, healthy adults (CRIS KCT0011710)
PubMed · 42392376Intravenous longevity therapy: a critical review of evidence, mechanisms, and clinical utility
Acta Dermatovenerologica Alpina, Pannonica et Adriatica · critical review of intravenous high-dose vitamin, amino acid, glutathione and NAD+ infusion protocols marketed as longevity therapy
PubMed · 41915584Liposomal glutathione outperforms plain glutathione in uptake, cell regeneration and systemic availability: evidence from cellular and human models
British Journal of Nutrition · HEK293T cell assays plus parallel-arm open-label human pharmacokinetic study, 12 healthy adults (6 per arm), single 1 g oral dose
PubMed · 41559937Safety of S-acetyl glutathione as an novel food pursuant to Regulation (EU) 2015/2283.
EFSA J · EFSA NDA Panel scientific opinion on S-acetyl glutathione as a novel food under EU Regulation 2015/2283
PubMed · 42683004The role of N-acetylcysteine and glutathione in the management of Parkinson's disease: a systematic review of oxidative biomarkers and clinical outcomes
Amino Acids · systematic review of 9 studies (2009-2019) totalling 196 participants with Parkinson's disease, comparing NAC or glutathione against placebo or healthy controls
PubMed · 41874704
Solo para fines de investigación. No apto para consumo humano, diagnóstico, tratamiento o prevención de ninguna condición. Nada en esta página constituye consejo médico.